China Resources Pharmaceutical Group Ltd. Financial Overview
China Resources Pharmaceutical Group Ltd.'s market cap is currently €31.10B. The company's EPS TTM is HK$; its P/E ratio is 10.23; and it has a dividend yield of 2.93%. China Resources Pharmaceutical Group Ltd. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$0.42. See an overview of income statement, balance sheet, and cash flow financials.
